Heparin-induced thrombocytopenia as a cause of prolonged low platelet count in a patient with thrombotic thrombocytopenic purpura treated with plasmapheresis

Acta Biochim Pol. 2017;64(2):375-376. doi: 10.18388/abp.2016_1428. Epub 2017 Apr 5.

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare disorder belonging to thrombotic microangiopathies (TMA) and is caused by functional deficiency of the ADAMTS-13 metalloproteinase. Plasma exchange (PE) remains the treatment of choice in this disease. Here, were describe the case of a patient who apparently recovered from TTP following multiple sessions of PE, but remained thrombocytopenic. Careful analysis revealed the development of heparin-induced thrombocytopenia (HIT) that precluded platelet count (PLT) normalization. Full normalization of PLT followed discontinuation of PE and low-molecular weight heparin.

Keywords: heparin-induced thrombocytopenia; plasma exchange; thrombotic thrombocytopenic purpura.

Publication types

  • Case Reports

MeSH terms

  • Heparin / administration & dosage
  • Heparin / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Plasmapheresis / adverse effects*
  • Platelet Count*
  • Purpura, Thrombotic Thrombocytopenic / blood
  • Purpura, Thrombotic Thrombocytopenic / pathology
  • Purpura, Thrombotic Thrombocytopenic / therapy*
  • Thrombocytopenia / blood
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / pathology

Substances

  • Heparin